Nabriva Therapeutics: Q3 Earnings Insights

Nabriva Therapeutics NBRV reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nabriva Therapeutics their estimated earnings by 12.5%, reporting an EPS of $-0.21 versus an estimate of $-0.24, which surprised analysts.

Revenue was up $7,571,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06, which was followed by a 0.86% increase in the share price the next day.

Here's a look at Nabriva Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.